New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies
Authors
Keywords
-
Journal
ARCHIV DER PHARMAZIE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-26
DOI
10.1002/ardp.202300340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Docking and simulation studies on cyclin D/CDK4 complex for targeting cell cycle arrest in cancer using flavanone and its congener
- (2023) Sagar Nagare et al. JOURNAL OF MOLECULAR MODELING
- New Natural Eugenol Derivatives as Antiproliferative Agents: Synthesis, Biological Evaluation, and Computational Studies
- (2023) Syed Nazreen et al. ACS Omega
- Structure-Based Virtual Screening of Furan-1,3,4-Oxadiazole Tethered N-phenylacetamide Derivatives as Novel Class of hTYR and hTYRP1 Inhibitors
- (2023) Ali Irfan et al. Pharmaceuticals
- Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
- (2022) Noor ul Amin Mohsin et al. Pharmaceuticals
- High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity
- (2021) Pavani Pingali et al. NEOPLASIA
- Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
- (2021) Dan Pu et al. Frontiers in Oncology
- Computational Study of SARS-CoV-2 RNA Dependent RNA Polymerase Allosteric Site Inhibition
- (2021) Shah Faisal et al. MOLECULES
- Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases
- (2020) Perihan A. Elzahhar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chemotherapy-related fever or infection fever?
- (2020) Nilgun Eroglu et al. SUPPORTIVE CARE IN CANCER
- Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
- (2020) Shuangshuang Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer in Africa 2018: The role of infections
- (2019) Donald M. Parkin et al. INTERNATIONAL JOURNAL OF CANCER
- New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies
- (2019) Nehad A. El-Sayed et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular modelling insights into a physiologically favourable approach to eicosanoid biosynthesis inhibition through novel thieno[2,3-b]pyridine derivatives
- (2018) Mosaad S. Mohamed et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity
- (2018) Fatima Naaz et al. BIOORGANIC CHEMISTRY
- Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking
- (2018) Walaa M. El-Husseiny et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes
- (2018) Nicole C. Howard et al. Nature Microbiology
- NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis
- (2017) Xiaoping Zhao et al. Scientific Reports
- Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy
- (2016) Hao Cai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
- (2015) Bing Liu et al. Cancer Cell International
- Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro
- (2015) XIAO-HANG CHE et al. ONCOLOGY REPORTS
- Radiation and Inflammation
- (2015) Dörthe Schaue et al. SEMINARS IN RADIATION ONCOLOGY
- Using Acetaminophen's Toxicity Mechanism to Enhance Cisplatin Efficacy in Hepatocarcinoma and Hepatoblastoma Cell Lines
- (2015) Alexander J. Neuwelt et al. NEOPLASIA
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- 5-((1-Aroyl-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-diones as potential anticancer agents with anti-inflammatory properties
- (2012) Narsimha Reddy Penthala et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The decrease of cell membrane fluidity by the non-steroidal anti-inflammatory drug Licofelone inhibits epidermal growth factor receptor signalling and triggers apoptosis in HCA-7 colon cancer cells
- (2012) Simona Tavolari et al. CANCER LETTERS
- Acetaminophen Induces Human Neuroblastoma Cell Death through NFKB Activation
- (2012) Inmaculada Posadas et al. PLoS One
- Acetaminophen-induced cytotoxicity on human normal liver L-02 cells and the protection of antioxidants
- (2010) Qingning Liang et al. TOXICOLOGY MECHANISMS AND METHODS
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started